Thread lift advertising rules for med spas and plastic surgery

Thread lifts are sold as the in-between option: more than filler, less than a facelift. Med spas and plastic surgery practices advertise “PDO thread lift,” “nonsurgical facelift,” “jawline threads” and “lunchtime lift” packages. The threads are sutures, and FDA clears sutures through 510(k) with stated indications. Some threads used in aesthetic practice are cleared only for closing soft tissue and their own FDA summaries say they are not intended for lifting. Others are cleared to hold the cheek in an elevated position. An ad that says “FDA-approved thread lift” can be wrong twice.

This guide covers how thread devices are cleared, how to check the indications of the threads you use, approval and clearance wording, and how results, risks, photos and prices fit under the FTC Act. For fillers, see our guide to dermal filler advertising rules. For surgical facelift and other procedure marketing, see our guide to plastic surgeon marketing.

The short version

• Threads are cleared sutures, not approved devices. The thread products we read went through 510(k) premarket notification. Under 21 CFR 807.97, a 510(k) clearance does not denote official FDA approval, and representing it as approval is misleading. Say “FDA-cleared” for the cleared indication, never “FDA-approved.”
• Indications differ from thread to thread. Two summaries we read clear barbed threads for face suspension or midface suspension surgery to fixate the cheek in an elevated position. Two others clear threads for soft tissue approximation only and say they are not intended for lifting and supporting tissues.
• Promoting a use outside the clearance is a problem. 21 USC 396 lets clinicians use a legally marketed device as they judge best for a patient, but it “shall not change any existing prohibition on the promotion of unapproved uses.”
• Results and risks follow FTC rules. How long a lift lasts, how it compares to surgery and what a typical patient sees are claims that need evidence (15 USC 45, 52; FTC guidance), and leaving out material risks can make an ad misleading (15 USC 55(a)(1)).

How FDA clears thread devices

Thread lift devices we found in FDA’s 510(k) data are classified as surgical sutures. 21 CFR 878.4840 covers absorbable polydioxanone (PDO) sutures, “intended for use in soft tissue approximation,” Class II. 21 CFR 878.5010 covers nonabsorbable polypropylene sutures, “indicated for use in soft tissue approximation.” Neither regulation mentions lifting. Lifting claims come from individual clearances, where a manufacturer showed FDA a specific indication.

Here is what five 510(k) summaries for barbed or thread-style sutures say, without product names:

• K191299 (June 14, 2019), a lift suture: “for use in Midface suspension surgery to fixate the cheek sub dermis in an elevated position.”
• K220549 (March 7, 2023), a family of PDO sutures: indicated for soft tissue approximation where a barbed absorbable suture is appropriate, and “also indicated for use in face suspension surgery to temporarily fixate the cheek sub dermis in an elevated position.”
• K192953 (August 27, 2020), polypropylene barbed threads: “indicated for general soft tissue approximation, excluding closure of the epidermis, where use of a non-absorbable suture is appropriate.” No lifting indication.
• K190245 (June 4, 2019), PDO barbed threads: soft tissue approximation, “on the skin for dermatological applications only,” and “not intended for lifting and supporting tissues.”
• K240389 (March 27, 2024), PDO sutures with a needle: soft tissue approximation, and “not intended for body cavity applications or lifting and supporting tissues and is intended for dermatological use only.”

The two lifting clearances name the cheek or midface. We did not find a clearance in these records naming the jawline, neck, brows, nose, buttocks or breasts. That does not prove none exists; it means you should check the specific thread you use before you advertise an area.

Check your threads before you write the ad

1. Get the 510(k) number. Ask your supplier in writing for the 510(k) number of each thread you stock, and look it up in FDA’s 510(k) database. Read the Indications for Use page in the summary, not the brochure.
2. Match every area to an indication. If the indication says cheek or midface suspension, an ad for a cheek or midface lift with that thread matches. A “neck lift” or “brow lift” with the same thread does not. If the indication is soft tissue approximation only and says not for lifting, do not advertise that thread for a lift at all.
3. Keep a list. Record each thread, its 510(k) number and decision date, and its indication, and review ads, menus and social posts against it when you change suppliers.
4. Name the treatment, not the brand. Describing the procedure by area and thread material keeps you out of manufacturer trademark rules and avoids implying an endorsement.

Clearance wording

21 CFR 807.97 says premarket notification “does not in any way denote official approval of the device,” and that any representation creating that impression is misleading and misbranding. The decision letters themselves say FDA determined the device is substantially equivalent to legally marketed devices and that the company may market it subject to general controls.

• Avoid: “FDA-approved thread lift,” “FDA-approved threads,” “the only FDA-approved nonsurgical facelift.”
• Workable, if true for your thread: “Our threads are FDA-cleared for midface suspension to hold the cheek in a lifted position.”
• Do not say a thread is cleared for an area its indication does not name, and do not call a thread a lift device if its summary says it is not intended for lifting.

Our guide to medical device marketing claims covers cleared, approved and registered wording across specialties.

Results, “nonsurgical facelift” and risks

The FTC Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that a marketer is equally responsible for implied claims. For thread lifts:

• Duration. “Lasts 2 years” or “permanent results” is an objective claim you need evidence for, for the thread and area you use. A clearance for holding the cheek “temporarily” is not evidence of a two-year result.
• Comparison with surgery. “Nonsurgical facelift” or “facelift results without surgery” compares thread results with a surgical facelift. Without evidence for that comparison, describe what the procedure is, a minimally invasive procedure that places sutures under the skin, rather than what it equals.
• Downtime and risk. “No downtime,” “no risk” and “no scars” are claims too. Under 15 USC 55(a)(1), whether an ad misleads includes what it fails to reveal about the consequences of use. Say that bruising, swelling and other effects can occur and that the clinician reviews risks at consultation.
• Who it suits. Do not imply that every patient is a candidate; candidacy is a clinical decision made at consultation.

Before and after photos

Under 16 CFR 255.2(a), an advertiser needs substantiation for what consumer endorsements convey, as if it had made the claim itself. Under 16 CFR 255.2(b), an endorsement about a central attribute is likely to be read as representative of what patients generally achieve, unless the ad clearly and conspicuously discloses the generally expected result. Thread lift photos taken on the day of treatment can show a different result from weeks later. Show the timing (“three months after treatment”), match lighting, angle and expression, use no filters or retouching, get written permission, and say that results vary. Our guide to patient testimonials and before-and-after photos covers consent and privacy.

Prices and packages

Thread pricing is often per thread or per area. Say which, and that the number of threads depends on the assessment, so a “$799 thread lift” headline does not become a different price at the chair. A “was $2,000, now $1,200” offer needs a former price you actually offered in good faith for a reasonably substantial period of time (16 CFR 233.1(a)). See our guide to was and now price claims.

An example (made up)

This illustration is invented to show how the rules fit together. A med spa posts: “FDA-approved PDO thread lift! Lift your jowls, neck and brows with zero downtime. Facelift results without surgery that last 2 years. $799, was $2,000.” The threads the med spa stocks are cleared for soft tissue approximation, and their summary says they are not intended for lifting and supporting tissues.

Fixes: with those threads, there is no lift claim to make, so the post goes. If the med spa switches to a thread cleared for midface suspension, the new post can say the threads are FDA-cleared to hold the cheek in a lifted position. “FDA-approved” becomes “FDA-cleared.” Jowls, neck and brows come out unless a stocked thread is cleared for those areas. “Zero downtime” becomes a line about bruising and swelling, “facelift results” and “last 2 years” go unless the med spa has evidence, and the price says per area, with the number of threads set at consultation. The $2,000 former price stays only if patients actually paid it.

Checklist

• Every thread you stock is listed with its 510(k) number, decision date and indication from the FDA summary.
• Every area in ads, menus and posts matches a stocked thread’s cleared indication; no lift ads for threads cleared only for soft tissue approximation (21 USC 396).
• “FDA-cleared” with the indication; never “FDA-approved” (21 CFR 807.97).
• No duration, permanence or facelift comparison claims without evidence (15 USC 45, 52; FTC guidance).
• No “no downtime,” “no risk” or “no scars”; effects and the consultation are mentioned (15 USC 55(a)(1)).
• Before and after photos are real, consented, unretouched, timed and labeled with typical results (16 CFR 255.2).
• Prices say per thread or per area; former prices were real (16 CFR 233.1).
• Who may place threads, and under what supervision, checked against your state’s rules.

How we help

We build service pages and campaigns for med spas and plastic surgery practices with device indications and claims checked against the sources above: website design, healthcare SEO for treatment searches, and lead generation campaigns. We do not give legal opinions on device status or scope of practice, and we are not a law firm.

Sources

• FDA 510(k) Premarket Notification database
• openFDA device 510(k) data (last updated October 19, 2026)
• FDA 510(k) K190245, PDO barbed suture (June 4, 2019)
• FDA 510(k) K191299, midface suspension suture (June 14, 2019)
• FDA 510(k) K192953, polypropylene barbed suture (August 27, 2020)
• FDA 510(k) K220549, PDO barbed sutures with face suspension indication (March 7, 2023)
• FDA 510(k) K240389, PDO suture (March 27, 2024)
• 21 CFR 878.4840: Absorbable polydioxanone surgical suture
• 21 CFR 878.5010: Nonabsorbable polypropylene surgical suture
• 21 CFR 807.97: Misbranding by reference to premarket notification
• 21 USC 396: Practice of medicine
• 15 USC 45: Unfair methods of competition unlawful
• 15 USC 52: Dissemination of false advertisements
• 15 USC 55: Additional definitions
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 16 CFR 233.1: Former price comparisons

More in Cash-pay, aesthetic and wellness care